According to a TechSci Research report titled “Global Aptamers Market – Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028,” the global aptamers market is projected to experience steady growth during the forecast period of 2024-2028. This growth can be attributed to the increasing utilization of aptamers in various fields such as research, diagnostics, and medicine. Additionally, the growing demand for cost-effective products and increased research activities in the pharmaceutical and biotechnology industries are expected to drive market growth. The rapid rise in infectious diseases worldwide will further contribute to the demand for the aptamers market. Furthermore, the growing research activities to evaluate the mechanism of action of nucleic acid aptamers for the treatment of age-related macular degeneration are expected to support market growth. Advancements in the generation, purification, and drug delivery for targeting specific cells have attracted the attention of researchers toward aptamers due to their competitive advantages, which will drive market growth.
However, the lack of proper guidelines on molecular development and a shortage of trained professionals may hinder the growth of the global aptamers market during the forecast period. Additionally, low adoption rates and a lack of awareness about the latest technologies in middle- and low-income countries could hamper market growth. Improper regulatory structures and challenges regarding efficiency and safety standards in clinical studies can further restrict the growth of the global aptamers market.
The aptamers market can be segmented by type, technology, application, end user, and region. In terms of type, the market includes DNA Aptamers, XNA Aptamers, and RNA Aptamers. The DNA Aptamers segment currently dominates the market and is expected to maintain its dominance throughout the forecast period. This can be attributed to the lower production cost, higher stability compared to other acid-based nucleic acid aptamers, and easy availability of DNA aptamers. Their growing application in diagnostics and therapeutics purposes will further drive market growth.
Based on application, the market can be categorized into therapeutics development, research & development, diagnostics, and others. The therapeutic development segment is expected to dominate during the forecast period, primarily due to the increasing number of clinical trials assessing aptamers for new therapies. Collaborative partnerships between aptamer companies and prominent pharmaceutical and biopharmaceutical firms, driven by the growing prevalence of chronic diseases and the development of new diagnostic kits for the detection of cancer and other diseases, will further drive market growth.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on “Aptamers Market” – https://www.techsciresearch.com/report/aptamers-market/14633.html
Major companies operating in the global aptamers market are:
- Aptamer Group
- Raptamer Discovery Group
- Somalogic Inc.
- Aptamer Sciences, Inc.
- Aptagen LLC.
- Maravai Lifesciences.
- Kaneka Corporation.
- Neoventures Biotechnology Inc.
- Aptus Biotech.
- Base Pair Biotechnologies.
Various companies operating in the market are following strategies such as mergers & acquisitions, collaborations & partnerships, among others in order to stay competitive and have an edge over other market players. Additionally, companies are developing kits, and treatments using aptamers. For instance, in February 2019, Base Pair Biotechnologies Inc developed point of care tests to diagnose neonatal abstinence syndrome based on aptamer with the SBIR grants assistance. Also, in January 2019, Aptamer Group announced that the AstraZeneca Company has agreed to collaborate to expand the aptamer technology application potential. With this collaboration, AstraZeneca will adapt to the aptamer groups technology to improve the advanced drug delivery vehicles named after aptamer drug conjugates.
Customers can also request for 10% free customization on this report.
“North America is expected to dominate in the global aptamers market due to the growing prevalence of chronic diseases across the region especially in the United States. Additionally, well established healthcare and pharmaceutical infrastructure within the region is further supporting the growth of aptamers market. Similarly, the growing interest of research laboratories in the aptamers fields is further expected to support the market growth during the forecast period.” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.
“Aptamers Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (DNA Aptamers, XNA Aptamers, RNA Aptamers), By Technology (SELEX, Others), By Application (Therapeutics Development, Research & Development, Diagnostics, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Contract Research Organizations, Others), By Region and Competition”, has evaluated the future growth potential of global aptamers market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the global aptamers market.
Download Free Sample Report- https://www.techsciresearch.com/sample-report.aspx?cid=14633
Related Reports:
Dementia and alzheimers disease treatment market
Europe biomarker technologies market
About TechSci Research:
TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
